10 Best Long-Term Dividend Stocks to Buy According to Billionaires

6. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Billionaire Holders: 17

Bristol-Myers Squibb Company (NYSE:BMY) ranks sixth on our list of the best dividend stocks for the long term, according to billionaires. The American multinational pharmaceutical company focuses on developing and delivering innovative medicines.

In the first quarter of 2025, Bristol-Myers Squibb Company (NYSE:BMY) reported revenue of $11.2 billion, down 5.6% from the same period last year. However, the revenue beat analysts’ estimates by over $494 million. The Growth Portfolio generated $5.6 billion in revenue, marking a 16% increase on a reported basis, or 18% excluding foreign exchange effects. This growth was mainly driven by Opdivo, Breyanzi, Reblozyl, and Camzyos, along with the strong early launch of Cobenfy in the US.

Bristol-Myers Squibb Company (NYSE:BMY)’s cash position remained strong. It ended the quarter with over $10.8 billion available in cash and cash equivalents, up from $10.3 billion at the end of December. The company pays a quarterly dividend of $0.62 per share, having raised it by 3.3% in December 2024. This marked its 16th consecutive year of dividend growth. In addition, BMY has been a consistent dividend payer for 93 years. As of April 27, the stock has a dividend yield of 5.18%.

As of the close of Q4 2024, 17 billionaires held stakes in Bristol-Myers Squibb Company (NYSE:BMY), worth nearly $1.9 billion in total. Israel Englander was one of the company’s leading stakeholders in Q4.